CG Oncology Biotech
Funding, team structure (meet the founders), partners and clients
Market - Biotech
Location - Irvine, USA
Description - CG Oncology is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.
Tags - Phase 3 BOND3 CG0070 BCG Non-Muscle Invasive Bladder Cancer NMIBC Phase 2 CORE1 KEYTRUDA Phase 1 CORE2 OPDIVO Muscle-Invasive Bladder Cancer MIBC
Team
Founder Arthur Kuan
Funding
CG Oncology raised $47,000,000 with Kissei Pharmaceutical Co and Perseverance Capital Management and ORI Healthcare Fund, Camford Capital - 12/10/2020